A new government report finds 40% of U.S. counties didn’t have a single healthcare provider approved to prescribe the opioid addiction medication buprenorphine in 2018.
Fewer than 10% of primary care physicians have received approval from the federal government to prescribe the opioid addiction medication buprenorphine, according to a study published in Annals of Internal Medicine.
Medication used to treat opioid addiction can be helpful for teens who misuse opioids, a new study suggests. Until now, the evidence for the effectiveness of medication-assisted treatment in teens has been unclear, HealthDay reports.
More Medicare patients are receiving medication-assisted treatment for opioid use disorder, according to a new report by the Department of Health and Human Services.
A new study using “secret shoppers” found patients who are uninsured or covered by Medicaid often have a difficult time getting an appointment with a doctor who prescribes the opioid addiction medication buprenorphine.
A study of outpatient treatment for opioid addiction finds white patients are almost 35 times more likely than black patients to have a visit related to the addiction treatment medication buprenorphine, Kaiser Health News reports.
A federal appeals court has ruled a Maine jail must provide an incarcerated woman with medications for her opioid use disorder, NPR report. The decision could have wide repercussions, according to legal advocates.
Medicaid expansion has led to increases in the number of people diagnosed with and treated for opioid addiction, according to a new study that focused on West Virginia.
The growing use of insurance pre-authorization rules has limited prescriptions of the addiction medication buprenorphine among Medicare patients in the past decade, a new study finds.
A new study finds only 36 percent of outpatient facilities that treat substance use disorder offer medication-assisted treatment for opioid use disorder.
Making the opioid addiction medication buprenorphine more widely available outweighs the risk the drug will be diverted, addiction experts tell NPR. President Trump is expected to sign a bill that would increase access to the medication.
Few young people with opioid use disorder receive medications approved by the Food and Drug Administration to treat their addiction within three months of diagnosis, a new study finds.
The Food and Drug Administration issued new scientific recommendations this week designed to encourage development of new medication-assisted treatment drugs for opioid use disorder.
People with a criminal conviction who have a history of opioid addiction may be less likely to die of an overdose or other causes when they are being treated with methadone, a new study concludes.
Fentanyl overdoses share many characteristics with heroin overdoses – with some important differences, according to an addiction specialist at Boston Medical Center’s Grayken Center for Addiction.
A new study concludes too few people who survive an opioid overdose receive medication-assisted treatment that will reduce the chance of another overdose.
This website uses cookies. We use cookies and similar technologies to give
you the best experience. By using this website, you accept our Privacy Policy and Terms of Use.
Get Support
